Complete-PsA

Canadian Active Drug Post Marketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis

Brief summary

The current study will assess the real - life effectiveness of an active drug in the management of articular and dermatological manifestations of moderate to severe Psoriatic Arthritis (PsA).

Observational study

Status:
Completed
Conditions:
Psoriatic Arthritis
Enrollment:
483 patients
Protocol ID:
P12-666
Observational model:
Cohort
Time perspective:
Prospective

 

Eligibility criteria

Participant attributes:
Male and Female

Age:

From 18 Years to 99 Years.

Inclusion Criteria:

- Adult >= 18 years old

- Has provided written informed consent allowing the use of their data for the study and
providing permission for contact by the study personnel

- Active Psoriatic Arthritis (PsA) with three (3) or more tender and swollen joints as
well as active psoriatic skin lesions or confirmed history of psoriasis

- Inadequate response or non-tolerant to current disease-modifying antirheumatic drugs
(DMARD) based treatment for PsA

Exclusion Criteria:

- Currently participating in another prospective study including controlled clinical
trials and observational studies

- Patient cannot or will not sign informed consent

- Stable disease with adequate tolerance and response to current treatment and no change
in treatment is indicated

- Previous treatment with anti-tumor necrosis factor (anti-TNF) or other biologic agent

All the cities where the clinical studies are located

Cranbrook - V1C 2R7
Kamloops - V2C 0B8
Kamloops - V2C 6G6
Nanaimo - V9S 4S1
Penticton - V2A 3G7
Richmond - V6X 2C7
Vancouver - V6Z 2E8
Victoria - V8P 5P6
St. John's - A1B 5E8
St. John's - A1C 5B8
Halifax - B3H 1V7
Sydney - B1S 3N1
Barrie - L4M 6L2
Bowmanville - L1C 1P6
Brockville - K6V 5J9
Burlington - L7L 0B7
Dundas - L9H 1B7
Hamilton - L8N 1Y2
Hamilton - L9C 5N2
Markham - L3P 1X2
Mississauga - L5A 3V8
Mississauga - L5M 2V8
Mississauga - L5M 4N4
Niagara Falls - L2E 6A6
Ottawa - K2P 1V3
Owen Sound - N4K 1S4
Richmond Hill - L4C 9M7
Toronto - M4S 2C6
Toronto - M6S 4W4
Toronto - M9C 5N2
Montreal - H2L 1S6
Montreal - H3T 1Y3
Outremont - H2V 3Z5
Rimouski - G5L 8W1
Sainte-foy - G1V 3M7
Sherbrooke - J1H 5N4
Trois-rivières - G8Z 1Y2
Westmount - H3Z 2Z3
Winnipeg - R3A IM3

More information about this study

clinicaltrials.gov